Skip to main content
Fig. 2 | Journal of Experimental & Clinical Cancer Research

Fig. 2

From: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer

Fig. 2

Expression changes of HOXD-AS1 after transfection of siRNA or tet-shRNA. a, b The si-HOXD-AS1 significantly reduced the expression level of HOXD-AS1 in 5637 (P < 0.001) and T24 (P = 0.002). c, d The tet-shRNA HOXD-AS1 induced by dox regulated the expression of HOXD-AS1 in a dosage-dependent manner in 5637 (P = 0.008) and T24 cells (P = 0.016)

Back to article page